Ultrasound Enhancing Agents Market Scope And Analysis

  • Report Code : TIPRE00039130
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Ultrasound-Enhancing Agents Market Size and Scope by 2031

Buy Now

Ultrasound-Enhancing Agents Market Report Ultrasound-Enhancing Agents Market Size and Share Ultrasound-Enhancing Agents Market Scope and Analysis

Ultrasound-Enhancing Agents Market Report Scope

Report Attribute Details
Market size in 2023 US$ 756.61 Million
Market Size by 2031 US$ 2,511.52 Million
Global CAGR (2023 - 2031) 16.2%
Historical Data 2021-2023
Forecast period 2023-2031
Segments Covered By Type
  • First Generation and Second Generation
By Application
  • Abdominal Imaging
  • Cardiovascular Imaging
  • Urinary Tract Imaging
By End User
  • Hospitals
  • Diagnostic and Imaging Centers
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Lantheus Holdings Inc
  • GE Healthcare
  • Solstice Pharmaceuticals BV
  • FUJIFILM VisualSonics Inc
  • Bracco Diagnostics Inc
  • Bayer AG
  • Vesselon
    		•

    Competitive Landscape and Key Companies:

    Lantheus Holdings Inc.; GE Healthcare; Solstice Pharmaceuticals B.V.; FUJIFILM VisualSonics, Inc.; Bracco Diagnostics Inc.; Bayer AG; and Vesselon are among the prominent companies profiled in the ultrasound-enhancing agents market report. These companies focus on new technologies, existing product advancements, and geographic expansions to meet the growing consumer demand worldwide.